Crossref
26-A-12006-ACC ESTIMATED PREVENTABLE CARDIOVASCULAR DISEASE EVENTS FROM LIPOPROTEIN(A) TARGETED THERAPY
JACC · 2026-04 · 87 (13) · A269
DOI: 10.1016/j.jacc.2026.02.668 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Nathan D. Wong und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wong, N. D., Karthikeyan, H., Fan, W., & Hu, X. (2026). 26-A-12006-ACC ESTIMATED PREVENTABLE CARDIOVASCULAR DISEASE EVENTS FROM LIPOPROTEIN(A) TARGETED THERAPY. JACC, 87(13), A269. https://doi.org/10.1016/j.jacc.2026.02.668
Vancouver
Wong ND, Karthikeyan H, Fan W, Hu X. 26-A-12006-ACC ESTIMATED PREVENTABLE CARDIOVASCULAR DISEASE EVENTS FROM LIPOPROTEIN(A) TARGETED THERAPY. JACC. 2026;87(13):A269. doi:10.1016/j.jacc.2026.02.668
BibTeX
@article{Wong2026,
author = {Wong, Nathan D. and Karthikeyan, Hridhay and Fan, Wenjun and Hu, Xingdi},
title = {26-A-12006-ACC ESTIMATED PREVENTABLE CARDIOVASCULAR DISEASE EVENTS FROM LIPOPROTEIN(A) TARGETED THERAPY},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A269},
doi = {10.1016/j.jacc.2026.02.668}
}
EUVIMED